S-Bank Fund Management Ltd

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2036461 HELSINKI, H9

Position in REGN

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$631,022

+$172,074 QoQ

Shares Held

1,012

+70.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#749

of 1,322 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

S-Bank Fund Management Ltd holds $2,967,528 across 5 Biotechnology names. REGN ranks #2 (21.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,034	$1,010,348
2	REGN	Regeneron Pharmaceuticals, Inc. This page	1,012	$631,022
3	ALNY	Alnylam Pharmaceuticals, Inc.	1,844	$555,099
4	RPRX	Royalty Pharma plc	7,365	$412,955
5	INCY	Incyte Corp	3,159	$358,104

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$631,022	1,012	+70.4%	Shares	Sole	2026-08-04
2026-03-31	$458,948	594	-3.6%	Shares	Sole	2026-05-11
2025-12-31	$475,471	616	-46.3%	Shares	Sole	2026-02-03
2025-09-30	$645,485	1,148	-1.3%	Shares	Sole	2025-10-27
2025-06-30	$610,575	1,163	+12.0%	Shares	Sole	2025-07-29
2025-03-31	$658,330	1,038	—	Shares	Sole	2025-05-13
No filing history on record for this holder in this stock.